TLR9 and glioblastoma: Kadiyala et al. [30] studied the ability of synthetic HDL (sHDL) nanodiscs as a chemoimmunotherapy for delivery of CpG, a Toll-like receptor 9 (TLR9) agonist, together with docetaxel (DTX), to the GBM microenvironment and elicit tumor regression.